CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study. [Phase 3]

Phase 3 pilot trial evaluating metolazone as an early add-on therapy for acute decompensated heart failure was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Aultman Health Foundation | Conditions: Acute Decompensated Heart Failure | Phase 3 | Status: TERMINATED | Results posted: 2019-02-15